EC 3.4.21.68: t-Plasminogen activator

HydrolasesOpen in Browse

CatLog read 194 records for EC 3.4.21.68 from 6 papers, for 2 organisms. Names in these papers: tissue type plasminogen activator (t-PA), tissue-type plasminogen activator (tPA), tissue-type plasminogen activator (single-chain tPA), tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) and 2 more.

Read from the paper by an AI model and checked against the paper by a second, separate AI run; code converted the units.

CatLog also holds 9 records for EC 3.4.21.68 that are not yet re-read: from its earlier version, built from the enzyme databases and partly checked against the papers. All records for EC 3.4.21.68 in Browse.

Papers

Papers with records for EC 3.4.21.68
PaperOrganismsRecords
Analysis of tissue plasminogen activator specificity using peptidyl fluorogenic substrates—76
Identification of a hydrophobic exosite on tissue type plasminogen activator that modulates specificity for plasminogenHomo sapiens60
Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitorsHomo sapiens29
The regulation by fibrinogen and fibrin of tissue plasminogen activator kinetics and inhibition by plasminogen activator inhibitor 1—12
Directing sequence-specific proteolysis to new targets. The influence of loop size and target sequence on selective proteolysis by tissue-type plasminogen activator and urokinase-type plasminogen…—9
Differences and Compatibility between Human and Porcine Fibrinolytic Components toward Plasmin Generation and Fibrin DegradationHomo sapiens, Sus scrofa8

Records

Records for EC 3.4.21.68 read from the paper
EnzymeOrganismSubstratekcat (s⁻¹)Km (mM)kcat/Km (mM⁻¹ s⁻¹)ConditionsPaperOpen record
tissue plasminogen activator (tPA)—H-D-Ile-Pro-Arg-pNA10.70.69415PMID 17408411Open record: tissue plasminogen activator (tPA), H-D-Ile-Pro-Arg-pNA
tissue plasminogen activator (tPA)—plasminogenplasminogen activation in buffer; no promoter——27PMID 17408411Open record: tissue plasminogen activator (tPA), plasminogen
tissue plasminogen activator (tPA)—plasminogen——140PMID 17408411Open record: tissue plasminogen activator (tPA), plasminogen
tissue plasminogen activator (tPA)—plasminogenplasminogen activation in fibrin clots; apparent kcat0.0271.09 × 10⁻⁴250PMID 17408411Open record: tissue plasminogen activator (tPA), plasminogen
tissue plasminogen activator (tPA)—plasminogenplasminogen activation in fibrin clots; apparent kcat0.0263.62 × 10⁻⁴70PMID 17408411Open record: tissue plasminogen activator (tPA), plasminogen
tissue plasminogen activator (tPA)—plasminogenplasminogen activation in fibrin clots; apparent kcat0.0281.19 × 10⁻⁴240PMID 17408411Open record: tissue plasminogen activator (tPA), plasminogen
tissue plasminogen activator (tPA)variant R275E (sctPA)—H-D-Ile-Pro-Arg-pNA7.31.465PMID 17408411Open record: tissue plasminogen activator (tPA) variant R275E (sctPA), H-D-Ile-Pro-Arg-pNA
tissue plasminogen activator (tPA)variant R275E (sctPA)—plasminogenplasminogen activation in buffer; no promoter——4PMID 17408411Open record: tissue plasminogen activator (tPA) variant R275E (sctPA), plasminogen
tissue plasminogen activator (tPA)variant R275E (sctPA)—plasminogen——160PMID 17408411Open record: tissue plasminogen activator (tPA) variant R275E (sctPA), plasminogen
tissue plasminogen activator (tPA)variant R275E (sctPA)—plasminogenplasminogen activation in fibrin clots; apparent kcat0.0238.7 × 10⁻⁵270PMID 17408411Open record: tissue plasminogen activator (tPA) variant R275E (sctPA), plasminogen
tissue plasminogen activator (tPA)variant R275E (sctPA)—plasminogenplasminogen activation in fibrin clots; apparent kcat0.0243.41 × 10⁻⁴70PMID 17408411Open record: tissue plasminogen activator (tPA) variant R275E (sctPA), plasminogen
tissue plasminogen activator (tPA)variant R275E (sctPA)—plasminogenplasminogen activation in fibrin clots; apparent kcat0.0238.6 × 10⁻⁵270PMID 17408411Open record: tissue plasminogen activator (tPA) variant R275E (sctPA), plasminogen
tissue type plasminogen activator (t-PA)Homo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.11.1 × 10⁻⁵9.1 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA), Lys-plasminogen
tissue type plasminogen activator (t-PA)Homo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0680.00514PMID 8999865Open record: tissue type plasminogen activator (t-PA), Lys-plasminogen
tissue type plasminogen activator (t-PA)Homo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline470.4120PMID 8999865Open record: tissue type plasminogen activator (t-PA), methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant F423AHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.121.4 × 10⁻⁵8.6 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant F423A, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant F423AHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.020.0045PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant F423A, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant F423AHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline490.598PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant F423A, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant F423A/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.22.2 × 10⁻⁵9.1 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant F423A/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant F423A/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0040.010.4PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant F423A/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant F423A/R275EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline27127PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant F423A/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant F423EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.182.3 × 10⁻⁵7.8 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant F423E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant F423EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0170.0053.4PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant F423E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant F423EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline570.5110PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant F423E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant F423E/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.151.5 × 10⁻⁵1 × 10⁴PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant F423E/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant F423E/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0030.0080.38PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant F423E/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant F423E/R275EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline280.931PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant F423E/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant L420AHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.171.9 × 10⁻⁵8.9 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant L420A, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant L420AHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0140.00114PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant L420A, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant L420AHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline450.4110PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant L420A, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant L420A/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.181.4 × 10⁻⁵1.3 × 10⁴PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant L420A/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant L420A/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0080.0090.89PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant L420A/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant L420A/R275EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline421.332PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant L420A/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant L420EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.172.1 × 10⁻⁵8.1 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant L420E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant L420EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0057 × 10⁻⁴7.1PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant L420E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant L420EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline450.4110PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant L420E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant L420E/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.151.8 × 10⁻⁵8.3 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant L420E/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant L420E/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0020.0050.4PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant L420E/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant L420E/R275EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline290.932PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant L420E/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant P422AHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.111.3 × 10⁻⁵8.5 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422A, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant P422AHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0280.0047PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422A, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant P422AHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline470.4120PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422A, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant P422A/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.151 × 10⁻⁵1.5 × 10⁴PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422A/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant P422A/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0070.0130.54PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422A/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant P422A/R275EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline321.227PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422A/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant P422EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.152.9 × 10⁻⁵5.2 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant P422EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.00157 × 10⁻⁴2.1PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant P422EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline490.4120PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant P422E/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.172.8 × 10⁻⁵6.1 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422E/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant P422E/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM5 × 10⁻⁴0.0050.1PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422E/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant P422E/R275EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline311.128PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422E/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant P422GHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.152.6 × 10⁻⁵5.8 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422G, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant P422GHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.00286 × 10⁻⁴4.7PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422G, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant P422GHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline600.6100PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422G, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant P422G/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.212.7 × 10⁻⁵7.8 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422G/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant P422G/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM8 × 10⁻⁴0.0040.2PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422G/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant P422G/R275EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline141.78.2PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant P422G/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.131 × 10⁻⁵1.3 × 10⁴PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0240.0171.4PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant R275EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline33133PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant S421EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.151.8 × 10⁻⁵8.3 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant S421E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant S421EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0160.0035.3PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant S421E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant S421EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline460.4120PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant S421E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant S421E/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.212.3 × 10⁻⁵9.1 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant S421E/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant S421E/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0020.0070.29PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant S421E/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant S421E/R275EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline262.311PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant S421E/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant S421GHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.111.6 × 10⁻⁵6.9 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant S421G, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant S421GHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0180.0044.5PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant S421G, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant S421GHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline360.490PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant S421G, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue type plasminogen activator (t-PA)variant S421G/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.0125-0.2 µM0.192.6 × 10⁻⁵7.3 × 10³PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant S421G/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant S421G/R275EHomo sapiensLys-plasminogenLys-plasminogen varied 0.9-15 µM0.0010.0040.25PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant S421G/R275E, Lys-plasminogen
tissue type plasminogen activator (t-PA)variant S421G/R275EHomo sapiensmethylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline234.65PMID 8999865Open record: tissue type plasminogen activator (t-PA) variant S421G/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline
tissue-type plasminogen activator (single-chain tPA)Homo sapiensD-alpha-aspartyl-glycyl-L-arginine 4-nitroanilide0.431.70.25pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), D-alpha-aspartyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensD-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide3.982.91.37pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), D-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensD-cyclohexylglycyl-glycyl-L-arginine 4-nitroanilide6.741.534.4pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), D-cyclohexylglycyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensD-hexahydrotyrosyl-glycyl-L-arginine 4-nitroanilide10.60.8312.8pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), D-hexahydrotyrosyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensD-lysyl-glycyl-L-arginine 4-nitroanilide6.322.13.01pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), D-lysyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensD-phenylalanyl-glycyl-L-arginine 4-nitroanilide7.460.710.7pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), D-phenylalanyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensL-alpha-aspartyl-glycyl-L-arginine 4-nitroanilide0.280.860.32pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), L-alpha-aspartyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensL-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide0.133.20.041pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), L-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensL-cyclohexylglycyl-glycyl-L-arginine 4-nitroanilide1.365.320.26pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), L-cyclohexylglycyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensL-phenylalanyl-glycyl-L-arginine 4-nitroanilide2.7921.4pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), L-phenylalanyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-benzyloxycarbonyl-D-alpha-aspartyl(beta-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide4.981.82.77pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-D-alpha-aspartyl(beta-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-benzyloxycarbonyl-D-alpha-glutamyl(gamma-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide4.481.23.73pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-D-alpha-glutamyl(gamma-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-benzyloxycarbonyl-D-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide7.462.62.87pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-D-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-benzyloxycarbonyl-D-arginyl-glycyl-L-arginine 4-nitroanilide8.530.5216.4pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-D-arginyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-benzyloxycarbonyl-D-phenylalanyl-glycyl-L-arginine 4-nitroanilide8.960.319.9pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-D-phenylalanyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-benzyloxycarbonyl-L-alpha-aspartyl(beta-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide1.842.30.8pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-L-alpha-aspartyl(beta-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-benzyloxycarbonyl-L-alpha-aspartyl-glycyl-L-arginine 4-nitroanilide0.350.720.49pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-L-alpha-aspartyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-benzyloxycarbonyl-L-alpha-glutamyl(gamma-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide1.290.91.43pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-L-alpha-glutamyl(gamma-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-benzyloxycarbonyl-L-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide0.752.20.34pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-L-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-benzyloxycarbonyl-L-valyl-glycyl-L-arginine 4-nitroanilide1.691.361.24pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-L-valyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-methoxycarbonyl-D-cyclohexylalanyl-glycyl-L-arginine 4-nitroanilide7.760.3422.8pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-methoxycarbonyl-D-cyclohexylalanyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-methoxycarbonyl-D-cyclohexylglycyl-glycyl-L-arginine 4-nitroanilide5.020.4211.9pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-methoxycarbonyl-D-cyclohexylglycyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-methoxycarbonyl-D-hexahydrotyrosyl-glycyl-L-arginine 4-nitroanilide8.310.3921.3pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-methoxycarbonyl-D-hexahydrotyrosyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-methoxycarbonyl-D-leucyl-glycyl-L-arginine 4-nitroanilide6.920.6211.2pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-methoxycarbonyl-D-leucyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-methoxycarbonyl-D-norleucyl-glycyl-L-arginine 4-nitroanilide6.820.996.89pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-methoxycarbonyl-D-norleucyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-methoxycarbonyl-D-valyl-glycyl-L-arginine 4-nitroanilide5.770.87.22pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-methoxycarbonyl-D-valyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-methylsulfonyl-D-phenylalanyl-glycyl-L-arginine 4-nitroanilide7.360.173.6pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-methylsulfonyl-D-phenylalanyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapiensN-tert-butoxycarbonyl-glycyl-glycyl-L-arginine 4-nitroanilide1.293.50.37pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), N-tert-butoxycarbonyl-glycyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (single-chain tPA)Homo sapienspyroglutamyl-glycyl-L-arginine 4-nitroanilide4.043.151.28pH 8, 25 °CPMID 9268299Open record: tissue-type plasminogen activator (single-chain tPA), pyroglutamyl-glycyl-L-arginine 4-nitroanilide
tissue-type plasminogen activator (t-PA)—staphylococcal nuclease variant (I), residues 44-51 of the 43-52 loop replaced by PFGRSA——0.02937 °CPMID 9468480Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (I), residues 44-51 of the 43-52 loop replaced by PFGRSA
tissue-type plasminogen activator (t-PA)—staphylococcal nuclease variant (II), residues 44-51 of the 43-52 loop replaced by PFGRSAG0.0180.0790.2337 °CPMID 9468480Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (II), residues 44-51 of the 43-52 loop replaced by PFGRSAG
tissue-type plasminogen activator (t-PA)—staphylococcal nuclease variant (III), residues 44-51 of the 43-52 loop replaced by PPFGRSAG0.0110.00991.137 °CPMID 9468480Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (III), residues 44-51 of the 43-52 loop replaced by PPFGRSAG
tissue-type plasminogen activator (t-PA)—staphylococcal nuclease variant (IV), residues 44-51 of the 43-52 loop replaced by PGPFGRSAG0.00750.00990.7637 °CPMID 9468480Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (IV), residues 44-51 of the 43-52 loop replaced by PGPFGRSAG
tissue-type plasminogen activator (t-PA)—staphylococcal nuclease variant (IX), residues 44-51 of the 43-52 loop replaced by PGSGRSASGTTGTG——0.01937 °CPMID 9468480Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (IX), residues 44-51 of the 43-52 loop replaced by PGSGRSASGTTGTG
tissue-type plasminogen activator (t-PA)—staphylococcal nuclease variant (V), residues 44-51 of the 43-52 loop replaced by PGPFGRSAGG0.010.00931.137 °CPMID 9468480Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (V), residues 44-51 of the 43-52 loop replaced by PGPFGRSAGG
tissue-type plasminogen activator (t-PA)—staphylococcal nuclease variant (VI), residues 44-51 of the 43-52 loop replaced by PHYGRSGG0.0120.0180.6737 °CPMID 9468480Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (VI), residues 44-51 of the 43-52 loop replaced by PHYGRSGG
tissue-type plasminogen activator (t-PA)—staphylococcal nuclease variant (VII), residues 44-51 of the 43-52 loop replaced by PQRGRSAG0.0060.00890.6737 °CPMID 9468480Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (VII), residues 44-51 of the 43-52 loop replaced by PQRGRSAG
tissue-type plasminogen activator (t-PA)—staphylococcal nuclease variant (VIII), residues 44-51 of the 43-52 loop replaced by PGSGRSAG3.7 × 10⁻⁴0.0170.02237 °CPMID 9468480Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (VIII), residues 44-51 of the 43-52 loop replaced by PGSGRSAG
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl1.470.393.8pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), (p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0570.0411.4pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.310.0983.2pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0890.0691.3pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0210.00742.9pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0740.0362.1pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.0440.0162.7pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.0820.0581.4pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.710.116.4pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—L-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.040.970.04pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), L-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—L-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.080.460.18pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), L-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0970.0156.3pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.540.0668.2pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.530.361.5pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.10.033.3pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.150.0473.2pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.490.0915.4pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.340.142.4pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.250.0269.5pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl1.030.07114.6pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-L-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.0110.0470.24pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-L-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-L-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.0840.10.83pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-L-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.370.01132.8pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), (p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0340.0113pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.170.01214.2pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.10.0176.2pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0180.011.9pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-diethyl (Table 4: D-FPR-ANSNR1R2 with R1 = C2H5, R2 = C2H5)0.140.121.2pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-diethyl (Table 4: D-FPR-ANSNR1R2 with R1 = C2H5, R2 = C2H5)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-hexamethylene (R1R2 = (CH2)6 ring) (Table 4: D-FPR-ANSNR1R2 with R1R2 = (CH2)6)0.220.0962.3pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-hexamethylene (R1R2 = (CH2)6 ring) (Table 4: D-FPR-ANSNR1R2 with R1R2 = (CH2)6)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(2-methoxyethyl) (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C2H4OCH3)0.660.144.7pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(2-methoxyethyl) (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C2H4OCH3)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(methoxycarbonylmethyl), i.e. glycine methyl ester (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = CH2COOCH3)0.150.0295.2pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(methoxycarbonylmethyl), i.e. glycine methyl ester (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = CH2COOCH3)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-benzyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C6H5CH2)0.540.02521.6pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-benzyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C6H5CH2)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.510.0776.6pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = c-C6H11)0.320.0883.6pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = c-C6H11)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-isopropyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = i-C3H7)0.20.0742.7pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-isopropyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = i-C3H7)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C4H9)0.470.0489.8pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C4H9)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-hexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C6H13)3.60.09537.9pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-hexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C6H13)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-tert-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = t-C4H9)0.940.08411.2pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-tert-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = t-C4H9)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.0250.00783.2pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.190.0335.8pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.160.008120.2pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.040.00854.7pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.20.008823.2pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0970.0137.3pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0470.0133.6pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0170.00266.4pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.150.0324.8pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.180.01412.8pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.250.01516.5pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.440.006666.5pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)Homo sapienshuman plasminogenporcine——190pH 7.4, 37 °CPMID 41567719Open record: tissue-type plasminogen activator (tPA), human plasminogen
tissue-type plasminogen activator (tPA)Homo sapienshuman plasminogenhuman——440pH 7.4, 37 °CPMID 41567719Open record: tissue-type plasminogen activator (tPA), human plasminogen
tissue-type plasminogen activator (tPA)Homo sapiensporcine plasminogenporcine——3.3pH 7.4, 37 °CPMID 41567719Open record: tissue-type plasminogen activator (tPA), porcine plasminogen
tissue-type plasminogen activator (tPA)Homo sapiensporcine plasminogenhuman——33pH 7.4, 37 °CPMID 41567719Open record: tissue-type plasminogen activator (tPA), porcine plasminogen
tissue-type plasminogen activator (tPA)Sus scrofahuman plasminogenporcine——26pH 7.4, 37 °CPMID 41567719Open record: tissue-type plasminogen activator (tPA), human plasminogen
tissue-type plasminogen activator (tPA)Sus scrofahuman plasminogenhuman——880pH 7.4, 37 °CPMID 41567719Open record: tissue-type plasminogen activator (tPA), human plasminogen
tissue-type plasminogen activator (tPA)Sus scrofaporcine plasminogenporcine——18pH 7.4, 37 °CPMID 41567719Open record: tissue-type plasminogen activator (tPA), porcine plasminogen
tissue-type plasminogen activator (tPA)Sus scrofaporcine plasminogenhuman——36pH 7.4, 37 °CPMID 41567719Open record: tissue-type plasminogen activator (tPA), porcine plasminogen
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.0990.0263.7pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), (p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.00840.0110.71pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0610.041.5pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0190.0141.3pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-diethyl (Table 4: D-FPR-ANSNR1R2 with R1 = C2H5, R2 = C2H5)0.090.320.28pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-diethyl (Table 4: D-FPR-ANSNR1R2 with R1 = C2H5, R2 = C2H5)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-hexamethylene (R1R2 = (CH2)6 ring) (Table 4: D-FPR-ANSNR1R2 with R1R2 = (CH2)6)0.130.250.52pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-hexamethylene (R1R2 = (CH2)6 ring) (Table 4: D-FPR-ANSNR1R2 with R1R2 = (CH2)6)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(2-methoxyethyl) (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C2H4OCH3)0.270.181.5pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(2-methoxyethyl) (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C2H4OCH3)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(methoxycarbonylmethyl), i.e. glycine methyl ester (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = CH2COOCH3)0.0830.0631.3pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(methoxycarbonylmethyl), i.e. glycine methyl ester (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = CH2COOCH3)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-benzyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C6H5CH2)0.450.0637.1pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-benzyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C6H5CH2)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0160.00572.8pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = c-C6H11)0.150.151pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = c-C6H11)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-isopropyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = i-C3H7)0.290.330.88pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-isopropyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = i-C3H7)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C4H9)0.330.122.8pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C4H9)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-hexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C6H13)1.10.09911.1pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-hexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C6H13)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-tert-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = t-C4H9)0.250.0793.2pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-tert-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = t-C4H9)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.0110.00731.5pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.0210.0220.95pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.0590.0252.3pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0120.0230.51pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0380.0152.5pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0220.021.1pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.010.0170.6pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.0190.0121.7pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.0360.0191.9pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.0650.0292.3pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.110.0167.1pH 7.4, 25 °CPMID 9047311Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl